Agency or Department Name Here (for pda/handhelds)

ADAA met with funded providers on January 3, 2008 to present guidelines for the dissemination of funding to regions for establishing/enhancing buprenorphine treatment delivery systems. Below are links to hand-outs from the meeting.

Buprenorphine Initiative Powerpoint Presentations

Buprenorphine Treatment and Delivery of Care ADAA Presentation Online - March 31, 2008 (In order to view this presentation, save it to your computer.  Presentaiton will open in powerpoint, from there select "Slide View" - "View Show").

ADAA Buprenorphine Initiative

• ADAA Buprenorphine Diversion Control
• Starting Up a Jurisdictional Buprenorphine Project
• Patient Information and Consent to Treatment with Buprenorphine (Sample)
• Agreement for Treatment with Subutex®/Suboxone® (Sample)
• Consent for Treatment with Buprenorphine (Sample)
• Vermont Practice Guidelines (Sample)
• SAMHSA's Tip 40 - Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
• SAMHSA's Tip 43 - Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs

BSAS Buprenorphine Initiative

• Baltimore Substance Abuse Systems, Inc. - Summary of Baltimore Buprenorphine Initiative Requirements (DRAFT) - December 19, 2007
• Buprenorphine Maintenance Treatment - Protocol for Follow-Up Appointments
• Buprenorphine Patient Transfer Summary (To Primary Care Providers for Buprenorphine Therapy)